ImaBiotech, a CRO company developing and offering mass spectrometry imaging (MSI) services, applications, and software, announces today a license agreement with Lawrence Berkeley National Laboratory (Berkeley Lab) to "OpenMSI" intellectual property to support ImaBiotech Multimaging™ technology.
ImaBiotech's Multimaging™ technology accelerates drug pharmacokinetic, pharmacology, toxicology, and formulation evaluation. Multimaging™ allows for ...